SCHEMBL28201887

SCHEMBL28201887

Cc1cc(C)cc(-c2cc(C(=O)O)c(C)c(C(=O)O)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.55
RXRB P28702 2/20 0.55
KDM4E B2RXH2 3/20 0.50
KMT2A Q03164 2/20 0.50
TPMT P51580 1/20 0.50
MEN1 O00255 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MCL1 Q07820 2/20 0.46
FTO Q9C0B1 1/20 0.45
AKR1C2 P52895 3/20 0.45
AKR1C1 Q04828 2/20 0.45
CNR2 P34972 1/20 0.43
CSNK2A1 P68400 1/20 0.42
ALDH1A1 P00352 1/20 0.41
HCAR1 Q9BXC0 1/20 0.39
GFER P55789 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
DHODH Q02127 1/20 0.38
AKR1C3 P42330 1/20 0.38
CFD P00746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392534 0.85 KDM4E (0.58) RXRARXRBKDM4EKMT2ATPMT
SCHEMBL27786187 0.80 PTPN1 (0.58) MCL1AKR1C2AKR1C1ALDH1A1DHODH
SCHEMBL28201890 0.79 TDP1 (0.53) RXRARXRBKDM4EKMT2AMEN1
SCHEMBL29898488 0.77 RXRA (0.50) RXRARXRBKDM4EKMT2ATPMT
SCHEMBL2806484 0.76 KDM4E (0.79) KDM4EKMT2ATPMTMEN1TDP1
SCHEMBL28026029 0.75 AKR1C2 (0.56) RXRARXRBKDM4EMCL1FTO
SCHEMBL12446321 0.74 TPMT (0.73) RXRARXRBTPMTCNR2ALDH1A1
SCHEMBL2808086 0.74 KDM4E (0.76) KDM4EKMT2ATPMTMEN1TDP1
SCHEMBL1259082 0.74 KDM4E (0.63) KDM4EKMT2ATPMTMEN1TDP1
SCHEMBL2280055 0.74 FTO (0.43) RXRARXRBKDM4ETPMTMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105164113-B Pyrroloamide inhibitors 艾伯维公司 2018-03-02 CN claimed
CN-105164113-B Pyrroloamide inhibitors 艾伯维公司 2018-03-02 CN disclosed